<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">mes</journal-id><journal-title-group><journal-title xml:lang="en">Extreme Medicine</journal-title><trans-title-group xml:lang="ru"><trans-title>Экстремальная биомедицина</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">3033-8964</issn><issn pub-type="epub">3033-8972</issn><publisher><publisher-name>Centre for Strategic Planning of the Federal Medical and Biological Agency</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.47183/mes.2025-301</article-id><article-id custom-type="elpub" pub-id-type="custom">mes-301</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>SPACE MEDICINE</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КОСМИЧЕСКАЯ МЕДИЦИНА</subject></subj-group></article-categories><title-group><article-title>Prospects of application of tear fluid analysis in aerospace medicine</article-title><trans-title-group xml:lang="ru"><trans-title>Перспективы применения анализа слезной жидкости в космической медицине</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9364-6369</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Cенчилов</surname><given-names>М. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Senchilov</surname><given-names>M. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сенчилов Михаил Олегович</p><p>Москва</p></bio><bio xml:lang="en"><p>Mikhail O. Senchilov</p><p>Moscow</p></bio><email xlink:type="simple">m.senchilov@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0048-0425</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Манько</surname><given-names>О. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Manko</surname><given-names>O. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Манько Ольга Михайловна, д-р мед. наук</p><p>Москва</p></bio><bio xml:lang="en"><p>Olga M. Manko, Dr. Sci. (Med.)</p><p>Moscow</p></bio><email xlink:type="simple">olgamanko@list.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0879-889X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Васильева</surname><given-names>Г. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Vasillieva</surname><given-names>G. U.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Васильева Галина Юрьевна, канд. мед. наук</p><p>Москва</p></bio><bio xml:lang="en"><p>Galina U. Vasillieva, Cand. Sci. (Med.)</p><p>Moscow</p></bio><email xlink:type="simple">galvassilieva@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное медико-биологическое агентство; Институт медико-биологических проблем РАН</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal Medical Biological Agency; Institute for Biomedical Problems of the Russian Academy of Sciences</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Институт медико-биологических проблем РАН</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Institute for Biomedical Problems of the Russian Academy of Sciences</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>26</day><month>06</month><year>2025</year></pub-date><volume>27</volume><issue>2</issue><fpage>191</fpage><lpage>196</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Senchilov M.O., Manko O.M., Vasillieva G.U., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Cенчилов М.О., Манько О.М., Васильева Г.Ю.</copyright-holder><copyright-holder xml:lang="en">Senchilov M.O., Manko O.M., Vasillieva G.U.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.extrememedicine.ru/jour/article/view/301">https://www.extrememedicine.ru/jour/article/view/301</self-uri><abstract><sec><title>Introduction</title><p>Introduction. The improvement of methods for remote health monitoring of astronauts, as well as the search for new noninvasive biomarkers of metabolic adaptation to microgravity conditions, are priority directions in the field of aerospace medicine.</p></sec><sec><title>Objective</title><p>Objective. To assess the possibility of using individual indicators of tear fluid in aerospace medicine.</p></sec><sec><title>Discussion</title><p>Discussion. A number of prospects for the application of human tear biomarkers to determine disorders occurring under the influence of spaceflight factors or during their imitation were identified. The use of filter paper is a priority method for collecting lachrymal fluid in spaceflight conditions due to its relative noninvasiveness and simplicity of sample preparation for assay. It was found that the unstimulated tear fluid contains proteins with an antibacterial activity: lysozyme, lipocalin, and secretory immunoglobulin A. The concentration of lysozyme in the tear fluid shows a marked increase relative to pre- and post-flight values. Changes in the concentration of natriuretic peptide, angiotensin II, dopamine, and α2-macroglobulin under conditions of real and simulated microgravity are described. A high diagnostic potential of determining the level of D-dimer in tear fluid under the influence of extreme factors of space flight was established.</p></sec><sec><title>Conclusions</title><p>Conclusions. The conducted literature review emphasizes the significant theoretical potential for the quantitative determination of natriuretic peptide, D-dimer, and individual components of the dopamine and renin-angiotensin-aldosterone systems in tear fluid for noninvasive diagnostics of pathological processes associated with spaceflight factors.</p></sec></abstract><trans-abstract xml:lang="ru"><sec><title>Введение</title><p>Введение. Усовершенствование методов дистанционного контроля состояния здоровья космонавтов, а также поиск новых неинвазивных биомаркеров метаболической адаптации к условиям микрогравитации являются приоритетными задачами космической медицины.</p></sec><sec><title>Цель</title><p>Цель. Оценка возможности использования анализа отдельных показателей слезной жидкости в космической медицине.</p></sec><sec><title>Обсуждение</title><p>Обсуждение. Выявлен ряд перспектив применения анализа состава слезы человека для определения биомаркеров различных нарушений организма, происходящих в условиях действия факторов космического полета и при их имитации. Приоритетным методом забора слезной жидкости в условиях космического полета является использование фильтровальной бумаги ввиду относительной атравматичности, простоты метода, более легкой пробоподготовки биообразцов для анализа. Установлено, что в нестимулированной слезной жидкости содержатся белки, обладающие антибактериальной активностью: лизоцим, липокалин и секреторный иммуноглобулин А, причем отмечено выраженное повышение концентрации лизоцима в слезной жидкости относительно до- и послеполетных величин. Описаны изменения концентраций натрийуретического пептида, ангиотензина-II, дофамина и α2-макроглобулина в условиях истинной и моделируемой микрогравитации. Обнаружен высокий диагностический потенциал определения уровня D-димера в слезной жидкости при воздействии экстремальных факторов космического полета.</p></sec><sec><title>Выводы</title><p>Выводы. На основании анализа данных литературы подчеркивается существенный теоретический потенциал применения количественного определения натрийуретического пептида, D-димера и отдельных компонентов дофаминовой и ренин-ангиотензин-альдостероновой систем в слезной жидкости для неинвазивной диагностики ассоциированных с факторами космического полета патологических процессов.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>слезная жидкость</kwd><kwd>сбор слезной жидкости</kwd><kwd>метаболизм слезной жидкости</kwd><kwd>космический полет</kwd><kwd>микрогравитация</kwd></kwd-group><kwd-group xml:lang="en"><kwd>tear fluid</kwd><kwd>tear fluid collection</kwd><kwd>tear fluid metabolism</kwd><kwd>spaceflight</kwd><kwd>microgravity</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа выполнена в рамках научной темы НИР «Изучение морфофункциональной устойчивости зрительной сенсорной системы при адаптации центральной нервной системы к действию экстремальных факторов среды» FMFR-2024-0034 (1023022700092-0-3.1.4;3.1.9;5.1.1).</funding-statement><funding-statement xml:lang="en">The study was carried out within the framework of the scientific research topic “The study of the morpho-functional stability of the visual sensory system during the adaptation of the central nervous system to the action of extreme environmental factors” FMFR-2024-0034 (1023022700092-0-3.1.4;3.1.9;5.1.1).</funding-statement></funding-group></article-meta></front><body><sec><title>INTRODUCTION</title><p>The habitability of space environments is associated with numerous medical and biological risks. Since the beginning of manned spaceflights, astronauts have shown significant adaptive shifts in water-salt metabolism due to changes in the parameters of the cardiovascular system and neurohormonal regulation. These shifts were shown to be determined by a volume regulatory reflex, manifested by clinically insignificant changes in the concentrations of osmotically active substances in the blood. At the same time, tight correlations between the initial vestibular vegetative stability of astronauts and the specifics of their neurohormonal changes under the influence of spaceflight factors were found [<xref ref-type="bibr" rid="cit1">1</xref>].</p><p>The initial period of weightlessness, due to blood redistribution toward the cranial direction, is associated with jumps in central and renal hemodynamics and is characterized by a decrease in the secretion of hormones of the renin-angiotensin-aldosterone system (RAAS) and antidiuretic hormone during the formation of a new fluid and electrolyte homeostasis with a negative balance of sodium and calcium [<xref ref-type="bibr" rid="cit2">2</xref>]. The observed hypohydration and hypovolemia, associated with primary adaptive hormonal mechanisms, contribute to an increase in the production of volume and osmoregulatory hormones [<xref ref-type="bibr" rid="cit3">3</xref>]. These reactions can lead to the development of pathological changes in cardiovascular and hemostatic systems, increase the risk of urolithiasis, and cause demineralization of bone tissue [<xref ref-type="bibr" rid="cit1">1</xref>].</p><p>Monitoring the metabolic adaptation of astronauts to microgravity is an essential aspect in the implementation of space missions. High-precision monitoring of physiological parameters of astronauts using molecular biomarkers is carried out by various methods. However, their analytical performance remains to be problematic, requiring modernization of current diagnostic procedures to minimize errors and facilitate the interpretation of the data obtained. Under conditions of spaceflight, selection of the most noninvasive biomaterial sampling techniques, which allow an informative qualitative and quantitative analysis, is of particular importance.</p><p>Tear fluid (TF) is one of the most accessible biological fluids for analysis, characterized by noninvasiveness of sampling and a widely studied composition equivalent to blood plasma [4-6]. Tear production is regulated by the autonomic nervous system, which allows the glands to rapidly adapt to changing environmental conditions and homeostasis disorders during the development of pathological processes [<xref ref-type="bibr" rid="cit7">7</xref>].</p><p>In this research, our aim was to evaluate the possibility of individual indicators of tear fluid as biomarkers in aerospace medicine.</p></sec><sec><title>MATERIALS AND METHODS</title><p>The literature search and review was performed using electronic bibliographic databases in the Russian (eLibrary, CyberLeninka) and English (Web of Science, Scopus, PubMed) languages. The search queries included the following key phrases: tear fluid, tear fluid collection, tear fluid metabolism, water-salt metabolism, homeostasis, osmoregulation, glomerular filtration, hormonal regulation, nonspecific protective factors, acute phase proteins, hemostasis system, dopamine system, biomarkers, hypokinesia, immersion, space flight, microgravity. The search depth was 10 years. The inclusion criteria were the availability of structured information on the methods of tear fluid collection, prognostic and diagnostic biomarkers of human body adaptation to the conditions of real spaceflight and during its simulation, qualitative and quantitative methods for their determination.</p></sec><sec><title>RESULTS AND DISCUSSION</title></sec><sec><title>Methods of collecting tear fluid</title><p>The TF sampling method may affect the TF composition. To date, tear collection for biochemical analysis is carried out by two principal methods: using microcapillary tubes with minimal irritation of the conjunctiva and by absorption using an absorbent material (filter paper, polyvinyl acetate sponges) [<xref ref-type="bibr" rid="cit8">8</xref>].</p><p>Sampling with microcapillary tubes without touching the eye provides optimal, unstimulated TF with minimal accompanying components for further research [<xref ref-type="bibr" rid="cit9">9</xref>]. However, due to the high risk of mechanical injury, this method requires the participation of specially trained personnel, which limits its use in routine practice [<xref ref-type="bibr" rid="cit4">4</xref>].</p><p>The advantage of filter paper in TF sampling consists in its relative noninvasiveness, implementation simplicity, and easier sample preparation [<xref ref-type="bibr" rid="cit10">10</xref>]. In addition, this method is applicable under the conditions of deficiency of the aqueous component of the tear film observed in microgravity [11, 12].</p></sec><sec><title>Antibacterial proteins and natriuretic peptides</title><p>Unstimulated TF contains about 20 g/L of proteins, most of which exhibit antibacterial activity, including lysozyme, lipocalin, and secretory immunoglobulin A [<xref ref-type="bibr" rid="cit7">7</xref>][<xref ref-type="bibr" rid="cit13">13</xref>]. Lysozyme, being the leading factor of nonspecific protection of TF, quantitatively prevails over other biological components [<xref ref-type="bibr" rid="cit14">14</xref>]. Thus, according to [<xref ref-type="bibr" rid="cit15">15</xref>], crewmembers of the International Space Station (ISS) during spaceflight showed a marked increase in the lysozyme concentration relative to pre- and post-flight values.</p><p>Natriuretic peptides (NPS) are a group of low molecular weight proteins, the main source of which in physiological conditions is atrial tissue [<xref ref-type="bibr" rid="cit16">16</xref>]. Currently, three types of NPS and their organic proteolysis products used in clinical diagnostic practice have been identified: atrial natriuretic peptides (ANP), brain natriuretic peptides (BNP), and type C natriuretic peptides (CNP) [<xref ref-type="bibr" rid="cit17">17</xref>]. The latter are a local regulatory factor of blood vessels and bones, not secreted into the blood [<xref ref-type="bibr" rid="cit18">18</xref>]. The main physiological effect of NPS concerns a reduction of the load of hemodynamic factors on the myocardium [<xref ref-type="bibr" rid="cit19">19</xref>]. In response to increased pressure on the cardiac wall, NPS cause fluid redistribution to the extravascular sector at the level of the capillary bed, venodilation, and natriuresis stimulation due to increased glomerular filtration rate and RAAS depression [<xref ref-type="bibr" rid="cit18">18</xref>][<xref ref-type="bibr" rid="cit20">20</xref>].</p><p>During the initial period of weightlessness and in simulated microgravity, a maximal increase in the NP level in blood plasma under a decrease in sympathetic influence was observed [<xref ref-type="bibr" rid="cit21">21</xref>][<xref ref-type="bibr" rid="cit22">22</xref>].</p><p>The researchers in [<xref ref-type="bibr" rid="cit23">23</xref>] studied the level of the N-terminal prohormone of brain natriuretic peptide (NT-proBNP), secreted in an equimolar BNP ratio and more stable upon release. A high correlation between the concentration of NT-proBNP in blood serum and TF was observed both in normal conditions and during the development of an ophthalmic pathology [23, 24].</p></sec><sec><title>Components of the renin-angiotensin-aldosterone system</title><p>The RAAS state plays an important role in the adaptation of water-electrolyte metabolism to spaceflight conditions, which significantly affect the kidneys osmoregulatory function [<xref ref-type="bibr" rid="cit25">25</xref>]. The main RAAS effector is the angiotensin-II (AT2) oligopeptide hormone [<xref ref-type="bibr" rid="cit26">26</xref>]. AT2 possesses vasoconstrictor properties, stimulates the production of aldosterone and antidiuretic hormone, increasing sodium reabsorption and contributing to the development of hypervolemia [<xref ref-type="bibr" rid="cit27">27</xref>].</p><p>During dry immersion experiments, a significant decrease in the plasma renin activity and serum AT2 concentration was revealed [<xref ref-type="bibr" rid="cit28">28</xref>][<xref ref-type="bibr" rid="cit29">29</xref>].</p><p>At the end of the last century, a local renin-angiotensin system was discovered in the human visual system with components (prorenin, renin, angiotensin converting enzyme, AT2) in concentrations exceeding those in blood plasma [<xref ref-type="bibr" rid="cit30">30</xref>].</p><p>At present, convincing data points to the diagnostic significance of AT2 determination in diabetic retinopathy (DR). Thus, according to the authors, in patients with DR, a significant increase in the concentration of AT2 in TF was recorded in close correlation with a similar indicator in the blood serum [<xref ref-type="bibr" rid="cit31">31</xref>].</p></sec><sec><title>Components of the dopamine system</title><p>The negative effects of microgravity on the brain dopamine system have also been described. A decrease in the expression of tyrosine hydroxylase during dopamine synthesis in the substantia nigra and a decrease in the expression of the dopamine receptor of the 1st subtype in the hypothalamus were noted [<xref ref-type="bibr" rid="cit32">32</xref>]. These changes may underlie motor disorders, dyskinesia, and Parkinsonism during and after space flight, which was shown in studies under the Bion-M1 program [<xref ref-type="bibr" rid="cit33">33</xref>][<xref ref-type="bibr" rid="cit34">34</xref>].</p><p>The involvement of dopaminergic neurons in the regulation of tear production leads to a higher TF level of dopamine and its metabolites compared to blood plasma [<xref ref-type="bibr" rid="cit35">35</xref>]. In [<xref ref-type="bibr" rid="cit36">36</xref>], a more than threefold excess of dopamine levels in tears over its plasma levels was observed, indicating a high diagnostic potential of TF as a noninvasive source of biomarkers of Parkinson’s disease (PD) and conditions accompanied by a decrease in the expression of dopamine system genes.</p></sec><sec><title>Acute phase proteins</title><p>The initial stage of the body’s adaptation to microgravity, in addition to the above, is accompanied by an increase in humoral inflammatory factors and changes in the hepatocyte synthesis of acute phase proteins (APPs) induced by inflammatory cytokines (interleukin-1β, interleukin-6, and tumor necrosis factor α) through interaction with liver cells [<xref ref-type="bibr" rid="cit37">37</xref>][<xref ref-type="bibr" rid="cit38">38</xref>].</p><p>In an experiment with seven-day dry immersion, the dynamics of APPs in blood plasma corresponding to the response acute phase was demonstrated. On the second day of exposure to simulated microgravity, statistically significant changes in plasma levels of haptoglobin, α1-antitrypsin, and α2-macroglobulin were observed [<xref ref-type="bibr" rid="cit39">39</xref>][<xref ref-type="bibr" rid="cit40">40</xref>].</p><p>α2-macroglobulin is an acute phase protein, an inhibitor of proteolytic enzymes with a wide spectrum of action. Upon the development of inflammatory reactions, it reduces damage to structural proteins by proteases released from leukocytes [<xref ref-type="bibr" rid="cit41">41</xref>]. Over the years, studies have repeatedly been conducted on the diagnostic significance of determining the activity of α2-macroglobulin in TF in ophthalmic and systemic pathologies [<xref ref-type="bibr" rid="cit42">42</xref>].</p><p>It was found that in patients with an early-stage PD and when modeling the preclinical stage of Parkinsonism in mice, the activity of TF α2-macroglobulin significantly exceeded the clinical norm. In addition, the high specificity of α2-macroglobulin activity (&gt;85%) was shown [<xref ref-type="bibr" rid="cit43">43</xref>], which validates the study of this protein as a biomarker of certain neurodegenerative diseases and conditions of the acute period of body adaptation to spaceflight conditions or during its simulation.</p></sec><sec><title>Components of the hemostasis system</title><p>Conditions accompanied by shifts in the hemostasis system and coagulation balance also affect the TF composition. In the acute period of exposure to microgravity, as mentioned above, hemodynamic shifts are observed, which in turn lead to changes in the rheological properties of the blood [<xref ref-type="bibr" rid="cit2">2</xref>][<xref ref-type="bibr" rid="cit44">44</xref>]. These changes, along with physical inactivity, may induce abdominal congestion, which increases the risk of developing thrombophilia in astronauts [<xref ref-type="bibr" rid="cit45">45</xref>]. A striking example is the case of occlusive thrombosis in an ISS crewmember during a recent orbital space flight [<xref ref-type="bibr" rid="cit46">46</xref>].</p><p>The determination of D-dimer (DD), which is a product of the proteolytic degradation of fibrin, is currently a widespread test for assessing the activity of fibrin formation and fibrinolysis processes [<xref ref-type="bibr" rid="cit47">47</xref>]. A number of studies have described significant changes in blood plasma DD levels during the period of adaptation to gravity unloading, with a tendency to be more pronounced in individuals with signs of vascular endothelial damage [<xref ref-type="bibr" rid="cit48">48</xref>][<xref ref-type="bibr" rid="cit49">49</xref>].</p><p>Tear fluid contains components of the hemostasis system. Thus, the researchers in [<xref ref-type="bibr" rid="cit50">50</xref>] demonstrated a high diagnostic informative value of antithrombin III and plasminogen levels in tears in patients with complicated diabetes mellitus and hypertensive angiosclerosis.</p><p>According to the results of a number of studies on determining the DD level in the TF, a statistically significant increase in the DD concentration was revealed in patients with retinal vein occlusion compared to the control group with minor changes in blood plasma [<xref ref-type="bibr" rid="cit51">51</xref>].</p><p>The risk of developing occlusive retinal lesions in real microgravity is probably due to the high level of the homocysteine neurotoxin in blood plasma, recorded in astronauts with ophthalmic pathology before and during a spaceflight mission [<xref ref-type="bibr" rid="cit52">52</xref>].</p><p>The above information justifies further investigation into the diagnostic potential of DD in tear fluid.</p><p>The adaptive restructuring of the water-electrolyte balance, recorded at an early stage of weightlessness exposure, may affect the mineral composition of tear fluid. Basal tear is characterized by high concentrations of potassium and sodium ions compared to blood serum, which ensures metabolic processes at the level of the ocular surface through Na, K-ATPase of the lacrimal glands [<xref ref-type="bibr" rid="cit53">53</xref>]. An increased level of calcium ions in TF is observed during bacterial infections, cystitis, and dry eye syndrome [<xref ref-type="bibr" rid="cit54">54</xref>][<xref ref-type="bibr" rid="cit55">55</xref>].</p></sec><sec><title>Pharmacological research</title><p>The acquisition of on-board first-aid kits remains relevant to the medical and biological support of manned space flights, taking into account the potential change in the pharmacological properties of individual drugs under the constant influence of extreme factors on astronauts. Pharmacokinetic studies of antiemetic, anti-inflammatory, and antibacterial agents, during flights demonstrated a significant decrease in the bioavailability of active substances relative to similar values on the Earth [<xref ref-type="bibr" rid="cit56">56</xref>]. To date, the retrospective analysis is limited by the heterogeneity of the conducted experiments [<xref ref-type="bibr" rid="cit57">57</xref>].</p><p>Despite the difficult-to-permeate blood-ocular barrier, a correlation between the concentrations of normothymic agents, macrolide, and beta-lactam antibiotics in blood plasma and TF was established [<xref ref-type="bibr" rid="cit58">58</xref>][<xref ref-type="bibr" rid="cit59">59</xref>]. A deeper understanding of the entry patterns of drugs and their metabolites into tear fluid is a promising task, the solution of which will contribute to optimization and standardization of methods for studying the pharmacokinetic and pharmacodynamic properties of various compounds for more effective formation of medical packages on board spacecraft.</p></sec><sec><title>CONCLUSION</title><p>The conducted literature review allow us to draw a preliminary conclusion about the high diagnostic and prognostic potential of TF analysis in a wide range of health pathologies and disorders detected under the impact of adverse spaceflight factors. Noninvasive and effortless under appropriate conditions, the study of tear composition appears to be a promising method for monitoring the state of functional systems, as well as for monitoring the correction of deviations in physiological parameters induced during space missions. The practical application of such studies involves the search for specific changes in the TF components, which can be sensitive biomarkers of the body adaptation to microgravity and, subsequently, to other extreme factors of outer space. In the long run, such studies may contribute to successful implementation of interplanetary expeditions.</p></sec></body><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Газенко ОГ, Григорьев АИ, Наточин ЮВ. Водно-солевой гомеостаз и космический полет. М.: Изд-во АН СССР; 1986.</mixed-citation><mixed-citation xml:lang="en">Gazenko OG, Grigoriev AI, Natochin UV. Water-salt homeostasis and space flight. Moscow: AN SSSR Publ.; 1986 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Носков ВБ. Адаптация водно-электролитного метаболизма к условиям космического полета и при его имитации. Физиология человека. 2013;39(5):119. https://doi.org/10.7868/s0131164613050111</mixed-citation><mixed-citation xml:lang="en">Noskov VB. Adaptation of water-electrolyte metabolism to the conditions of space flight and during its simulation. Human physiology. 2013;39(5):119 (In Russ.). https://doi.org/10.7868/s0131164613050111</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Поляков ВВ, Носков ВБ. Метаболические исследования в 438-суточном космическом полете. Авиакосмическая и экологическая медицина. 2005;39(3):9–13. EDN: NYYCEO</mixed-citation><mixed-citation xml:lang="en">Poljakov VV, Noskov VB. Metabolic investigations in the 438-day space flight. Aerospace and environmental medicine. 2005;39(3):9–13 (In Russ.). EDN: NYYCEO</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Ponzini E, Santambrogio C, De Palma A, Mauri P, Tavazzi S, Grandori R. Mass spectrometry-based tear proteomics for noninvasive biomarker discovery. Mass Spectrometry Reviews. 2022;41(5):842–60. https://doi.org/10.1002/mas.21691</mixed-citation><mixed-citation xml:lang="en">Ponzini E, Santambrogio C, De Palma A, Mauri P, Tavazzi S, Grandori R. Mass spectrometry-based tear proteomics for noninvasive biomarker discovery. Mass Spectrometry Reviews. 2022;41(5):842–60. https://doi.org/10.1002/mas.21691</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Jones G, Altman J, Ahmed S, Lee T, Zhi W, Sharma S, Sharma A. Unraveling the Intraday Variations in the Tear Fluid Proteome. Investigative Ophthalmology &amp; Visual Science. 2024;65(3):2. https://doi.org/10.1167/iovs.65.3.2</mixed-citation><mixed-citation xml:lang="en">Jones G, Altman J, Ahmed S, Lee T, Zhi W, Sharma S, Sharma A. Unraveling the Intraday Variations in the Tear Fluid Proteome. Investigative Ophthalmology &amp; Visual Science. 2024;65(3):2. https://doi.org/10.1167/iovs.65.3.2</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Чеснокова НБ, Павленко ТА, Безнос ОВ, Нодель МР. Слезная жидкость как источник биомаркеров нейродегенеративных процессов в центральной нервной системе. Российский неврологический журнал. 2023; 28(5):5–13. https://doi.org/10.30629/2658-7947-2023-28-5-5-13</mixed-citation><mixed-citation xml:lang="en">Chesnokova NB, Pavlenko TA, Beznos OV, Nodel MR. Lacrimal fluid as a source of biomarkers of neurodegenerative processes in the central nervous system. Russian neurological journal. 2023; 28(5):5–13 (In Russ.). https://doi.org/10.30629/2658-7947-2023-28-5-5-13</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Сомов ЕЕ, Бржеский ВВ. Слеза (физиология, методы исследования, клиника). Спб.: Наука, 1994. 156 с.</mixed-citation><mixed-citation xml:lang="en">Somov EE, Brzheskij VV. Tear (physiology, research methods, clinic). Saint-Peterburg: Nauka Publ.. 1994. 156 p. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Pieczynski J, Szulc U, Harazna J, Szulc A, Kiewisz J. Tear fluid collection methods: Review of current techniques. European Journal of Ophthalmology. 2021;31(5):2245–51. https://doi.org/10.1177/1120672121998922</mixed-citation><mixed-citation xml:lang="en">Pieczynski J, Szulc U, Harazna J, Szulc A, Kiewisz J. Tear fluid collection methods: Review of current techniques. European Journal of Ophthalmology. 2021;31(5):2245–51. https://doi.org/10.1177/1120672121998922</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Van Haeringen N. Clinical biochemistry of tears. Survey of ophthalmology.1981;26(2):84–96. https://doi.org/10.1016/0039-6257(81)90145-4</mixed-citation><mixed-citation xml:lang="en">Van Haeringen N. Clinical biochemistry of tears. Survey of ophthalmology.1981;26(2):84–96. https://doi.org/10.1016/0039-6257(81)90145-4</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Qin W, Zhao C, Zhang L, Wang T, Gao Y. A Dry Method for Preserving Tear Protein Samples. Biopreserv Biobank. 2017;15(5):417–21. https://doi.org/10.1016/j.jconrel.2021.06.042</mixed-citation><mixed-citation xml:lang="en">Qin W, Zhao C, Zhang L, Wang T, Gao Y. A Dry Method for Preserving Tear Protein Samples. Biopreserv Biobank. 2017;15(5):417–21. https://doi.org/10.1016/j.jconrel.2021.06.042</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Barmada A, Shippy A. Quantifying Sample Collection and Processing Impacts on Fiber-Based Tear Fluid Chemical Analysis. Translational Vision Science &amp; Technology.2020;9(10):23. https://doi.org/10.1167/tvst.9.10.23</mixed-citation><mixed-citation xml:lang="en">Barmada A, Shippy A. Quantifying Sample Collection and Processing Impacts on Fiber-Based Tear Fluid Chemical Analysis. Translational Vision Science &amp; Technology.2020;9(10):23. https://doi.org/10.1167/tvst.9.10.23</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Suh A, Ong J, Waisberg E, Lee A. Neurostimulation as a technology countermeasure for dry eye syndrome in astronauts. Life Sciences in Space Research. 2024;42:37–9. https://doi.org/10.1016/j.lssr.2024.04.003</mixed-citation><mixed-citation xml:lang="en">Suh A, Ong J, Waisberg E, Lee A. Neurostimulation as a technology countermeasure for dry eye syndrome in astronauts. Life Sciences in Space Research. 2024;42:37–9. https://doi.org/10.1016/j.lssr.2024.04.003</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Lepine M, Zambito O, Sleno L. Targeted Workflow Investigating Variations in the Tear Proteome by Liquid Chromatography Tandem Mass Spectrometry. ACS omega. 2023;8(34):31168–77. https://doi.org/10.1021/acsomega.3c03186</mixed-citation><mixed-citation xml:lang="en">Lepine M, Zambito O, Sleno L. Targeted Workflow Investigating Variations in the Tear Proteome by Liquid Chromatography Tandem Mass Spectrometry. ACS omega. 2023;8(34):31168–77. https://doi.org/10.1021/acsomega.3c03186</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Shannon A, Adelman S, Hisey E, Potnis S, Rozo V, Yung M, Li J, Murphy C, Thomasy S, Leonard B. Antimicrobial Peptide Expression at the Ocular Surface and Their Therapeutic Use in the Treatment of Microbial Keratitis. Frontiers in Microbiology. 2022;13:857735. https://doi.org/10.3389/fmicb.2022.857735</mixed-citation><mixed-citation xml:lang="en">Shannon A, Adelman S, Hisey E, Potnis S, Rozo V, Yung M, Li J, Murphy C, Thomasy S, Leonard B. Antimicrobial Peptide Expression at the Ocular Surface and Their Therapeutic Use in the Treatment of Microbial Keratitis. Frontiers in Microbiology. 2022;13:857735. https://doi.org/10.3389/fmicb.2022.857735</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Agha N, Baker F, Kunz H, Spielmann G, Mylabathula P, Rooney B, et al. Salivary antimicrobial proteins and stress biomarkers are elevated during a 6-month mission to the International Space Station. Journal of Applied Physiology. 2020;128(2):264–75. https://doi.org/10.1152/japplphysiol.00560.2019</mixed-citation><mixed-citation xml:lang="en">Agha N, Baker F, Kunz H, Spielmann G, Mylabathula P, Rooney B, et al. Salivary antimicrobial proteins and stress biomarkers are elevated during a 6-month mission to the International Space Station. Journal of Applied Physiology. 2020;128(2):264–75. https://doi.org/10.1152/japplphysiol.00560.2019</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Козлов ИА, Харламова ИЕ. Натрийуретические пептиды: биохимия, физиология, клиническое значение. Общая реаниматология. 2009;5(1):89–97. EDN: KVNFCN</mixed-citation><mixed-citation xml:lang="en">Kozlov IA, Harlamova IE. Natriuretic peptides: biochemistry, physiology, clinical significance. General reanimatology. 2009;5(1):89–97 (In Russ.). EDN: KVNFCN</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Коростышевская ИМ, Максимов ВФ. Где и когда в сердце секретируются натрийуретические пептиды. Онтогенез. 2012;43(3):217. EDN: OXXYNR</mixed-citation><mixed-citation xml:lang="en">Korostyshevskaja IM, Maksimov VF. Where and when natriuretic peptides are secreted in the heart. Ontogenesis. 2012;43(3):217 (In Russ.). EDN: OXXYNR</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Maack T. The broad homeostatic role of natriuretic peptides. Arquivos Brasileiros de Endocrinologia &amp; Metabologia. 2006;50:198–207. https://doi.org/10.1590/s0004-27302006000200006</mixed-citation><mixed-citation xml:lang="en">Maack T. The broad homeostatic role of natriuretic peptides. Arquivos Brasileiros de Endocrinologia &amp; Metabologia. 2006;50:198–207. https://doi.org/10.1590/s0004-27302006000200006</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Levin E, Samad M, Malempati S, Restini C. Natriuretic Peptides as Biomarkers: Narrative Review and Considerations in Cardiovascular and Respiratory Dysfunctions. The Yale Journal of Biology and Medicine. 2023;96(1):137–49. https://doi.org/10.59249/NCST6937</mixed-citation><mixed-citation xml:lang="en">Levin E, Samad M, Malempati S, Restini C. Natriuretic Peptides as Biomarkers: Narrative Review and Considerations in Cardiovascular and Respiratory Dysfunctions. The Yale Journal of Biology and Medicine. 2023;96(1):137–49. https://doi.org/10.59249/NCST6937</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Vesely D. Natriuretic peptides and acute renal failure. American Journal of Physiology-Renal Physiology. 2003;285(2):167–77. https://doi.org/10.1152/ajprenal.00259.2002</mixed-citation><mixed-citation xml:lang="en">Vesely D. Natriuretic peptides and acute renal failure. American Journal of Physiology-Renal Physiology. 2003;285(2):167–77. https://doi.org/10.1152/ajprenal.00259.2002</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Fortney S. Development of lower body negative pressure as a countermeasure for orthostatic intolerance.The Journal of Clinical Pharmacology. 1991;31(10):888–92. https://doi.org/10.1002/j.1552-4604.1991.tb03644.x</mixed-citation><mixed-citation xml:lang="en">Fortney S. Development of lower body negative pressure as a countermeasure for orthostatic intolerance.The Journal of Clinical Pharmacology. 1991;31(10):888–92. https://doi.org/10.1002/j.1552-4604.1991.tb03644.x</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Kvetnansky R, Noskov V, Blazicek P, Macho L, Grigoriev A, Goldstein D, Kopin I. New approaches to evaluate sympathoadrenal system activity in experiments on Earth and in space. Acta Astronautica. 1994;34:243–54. https://doi.org/10.1016/0094-5765(94)90261-5</mixed-citation><mixed-citation xml:lang="en">Kvetnansky R, Noskov V, Blazicek P, Macho L, Grigoriev A, Goldstein D, Kopin I. New approaches to evaluate sympathoadrenal system activity in experiments on Earth and in space. Acta Astronautica. 1994;34:243–54. https://doi.org/10.1016/0094-5765(94)90261-5</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Соснин ДЮ, Гаврилова ТВ, Ларин АЭ, Ненашева ОЮ, Кривцов АВ, Черешнева МВ. Концентрация мозгового натрийуретического пептида в слезе и сыворотке крови. Клиническая лабораторная диагностика. 2017;62(12);719–24.</mixed-citation><mixed-citation xml:lang="en">Sosnin DU, Gavrilova TV, Larin AE, Nenasheva OU, Krivcov AV, Chereshneva MV. The concentration of the cerebral natriuretic peptide in the tear and blood serum.Clinical laboratory diagnostics. 2017;62(12);719–24 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Omran F, Kyrou I, Osman F, Lim V, Randeva H, Chatha K. Cardiovascular Biomarkers: Lessons of the Past and Prospects for the Future. International Journal of Molecular Sciences. 2022;23(10):5680. https://doi.org/10.3390/ijms23105680</mixed-citation><mixed-citation xml:lang="en">Omran F, Kyrou I, Osman F, Lim V, Randeva H, Chatha K. Cardiovascular Biomarkers: Lessons of the Past and Prospects for the Future. International Journal of Molecular Sciences. 2022;23(10):5680. https://doi.org/10.3390/ijms23105680</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Григорьев АИ, Ларина ИМ. Водно-солевой обмен и функции почек у человека при длительной гипокинезии. Нефрология. 2001;5(3):7–18.</mixed-citation><mixed-citation xml:lang="en">Grigoriev AI, Larina IM. Water-salt metabolism and kidney function in humans with prolonged hypokinesia. Nephrology. 2001;5(3):7–18 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Li X, Fu Y, Tong X, Zhang Y, Shan Y, Xu Y, et al. RAAS in diabetic retinopathy: mechanisms and therapies. Archives of Endocrinology and Metabolism. 2024;68:e230292. https://doi.org/10.20945/2359-4292-2023-0292</mixed-citation><mixed-citation xml:lang="en">Li X, Fu Y, Tong X, Zhang Y, Shan Y, Xu Y, et al. RAAS in diabetic retinopathy: mechanisms and therapies. Archives of Endocrinology and Metabolism. 2024;68:e230292. https://doi.org/10.20945/2359-4292-2023-0292</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Пастушкова ЛХ, Доброхотов ИВ, Веселова ОМ, Тийс ИС, Кононихин АС, Новоселова АМ и др. Идентификация белков сердечно-сосудистой системы у здоровых лиц в «сухой» иммерсии посредством изучения протеомного профиля мочи. Физиология человека. 2014;40(3):109. https://doi.org/10.7868/S0131164614030126</mixed-citation><mixed-citation xml:lang="en">Pastushkova LH, Dobrohotov IV, Veselova OM, Tijs IS, Kononihin AS, Novoselova AM, et al. Identification of proteins of the cardiovascular system in healthy individuals in «dry» immersion by studying the proteomic profile of urine. Human physiology. 2014;40(3):109 (In Russ.). https://doi.org/10.7868/S0131164614030126</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Pakharukova NA, Pastushkova LKh, Larina IM, Grigoriev AI. Changes of human serum proteome profile during 7-day “dry” immersion. Acta Astronautica. 2011;68(9–10):1523–28. https://doi.org/10.1016/j.actaastro.2009.10.014</mixed-citation><mixed-citation xml:lang="en">Pakharukova NA, Pastushkova LKh, Larina IM, Grigoriev AI. Changes of human serum proteome profile during 7-day “dry” immersion. Acta Astronautica. 2011;68(9–10):1523–28. https://doi.org/10.1016/j.actaastro.2009.10.014</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Ларина ИМ, Попова ИА, Михайлов ВМ, Буравкова ЛБ. Гормональные механизмы обеспечения мышечной работы во время длительной антиортостатической гипокинезии. Физиология человека. 1999;25(3):117–24.</mixed-citation><mixed-citation xml:lang="en">Larina IM, Popova IA, Mihajlov VM, Buravkova LB. Hormonal mechanisms for ensuring muscle function during prolonged antiorthostatic hypokinesia. Human physiology. 1999;25(3):117–24 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Choudhary R, Kapoor M, Singh A, Bodakhe S. Therapeutic targets of renin-angiotensin system in ocular disorders. Journal of current ophthalmology. 2017;29(1):7–16. https://doi.org/10.1016/j.joco.2016.09.009</mixed-citation><mixed-citation xml:lang="en">Choudhary R, Kapoor M, Singh A, Bodakhe S. Therapeutic targets of renin-angiotensin system in ocular disorders. Journal of current ophthalmology. 2017;29(1):7–16. https://doi.org/10.1016/j.joco.2016.09.009</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Нероев ВВ, Чеснокова НБ, Охоцимская ТД, Павленко ТА., Безнос ОВ, Фадеева ВА и др. Определение ангиотензина II в слезной жидкости и сыворотке крови у больных с диабетической ретинопатией. Таврический медико-биологический вестник. 2019;22(3):32–6. EDN: UGELFP</mixed-citation><mixed-citation xml:lang="en">Neroev VV, Chesnokova NB, Ohocimskaja TD, Pavlenko TA, Beznos O V, Fadeeva VA, et al. Determination of angiotensin II in lacrimal fluid and blood serum in patients with diabetic retinopathy. Tauride medical biological bulletin. 2019;22(3):32–6 (In Russ.). EDN: UGELFP</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Reschke M, Clement G. Vestibular and sensorimotor dysfunction during space flight. Current Pathobiology Reports. 2018;6:177–83. https://doi.org/10.1007/s40139-018-0173-y</mixed-citation><mixed-citation xml:lang="en">Reschke M, Clement G. Vestibular and sensorimotor dysfunction during space flight. Current Pathobiology Reports. 2018;6:177–83. https://doi.org/10.1007/s40139-018-0173-y</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Seidler R, Mao X, Tays G, Wang T, Eulenburg P. Effects of space-flight on the brain. The Lancet Neurology. 2024; 23(8):826–35. https://doi.org/10.1016/S1474-4422(24)00224-2</mixed-citation><mixed-citation xml:lang="en">Seidler R, Mao X, Tays G, Wang T, Eulenburg P. Effects of space-flight on the brain. The Lancet Neurology. 2024; 23(8):826–35. https://doi.org/10.1016/S1474-4422(24)00224-2</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Цыбко АС, Ильчибаева ТВ, Попова НК. Влияние космического полета на экспрессию генов в головном мозге экспериментальных животных. Вавиловский журнал генетики и селекции. 2016;20(2):172–9. https://doi.org/10.18699/VJ16.134</mixed-citation><mixed-citation xml:lang="en">Cybko AS, Ilchibaeva TV, Popova NK. The effect of space flight on gene expression in the brains of experimental animals. Vavilov Journal of Genetics and Breeding. 2016;20(2):172–9 (In Russ.). https://doi.org/10.18699/VJ16.134</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Ji W, Kang H, Song S, Jun W, Han K, Kim T, et al. The Dopaminergic Neuronal System Regulates the Inflammatory Status of Mouse Lacrimal Glands in Dry Eye Disease. Investigative Ophthalmology &amp; Visual Science. 2021;62(4):14. https://doi.org/10.1167/iovs.62.4.14</mixed-citation><mixed-citation xml:lang="en">Ji W, Kang H, Song S, Jun W, Han K, Kim T, et al. The Dopaminergic Neuronal System Regulates the Inflammatory Status of Mouse Lacrimal Glands in Dry Eye Disease. Investigative Ophthalmology &amp; Visual Science. 2021;62(4):14. https://doi.org/10.1167/iovs.62.4.14</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Sharma N, Acharya S, Nair A, Matalia J, Shetty R, Ghosh A. Dopamine levels in human tear fluid. Indian Journal of Ophthalmology. 2019;67(1):38–41. https://doi.org/10.4103/ijo.IJO_568_18</mixed-citation><mixed-citation xml:lang="en">Sharma N, Acharya S, Nair A, Matalia J, Shetty R, Ghosh A. Dopamine levels in human tear fluid. Indian Journal of Ophthalmology. 2019;67(1):38–41. https://doi.org/10.4103/ijo.IJO_568_18</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Larina O, Bekker A. Study of individual patterns of blood protein control during simulation of microgravity effects on humans. Human Physiology. 2012;38(7):753–6. https://doi.org/10.1134/S0362119712070110</mixed-citation><mixed-citation xml:lang="en">Larina O, Bekker A. Study of individual patterns of blood protein control during simulation of microgravity effects on humans. Human Physiology. 2012;38(7):753–6. https://doi.org/10.1134/S0362119712070110</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Mantovani A, Garlanda C. Humoral Innate Immunity and Acute-Phase Proteins. New England Journal of Medicine. 2023;388(5):439–52. https://doi.org/10.1056/NEJMra2206346</mixed-citation><mixed-citation xml:lang="en">Mantovani A, Garlanda C. Humoral Innate Immunity and Acute-Phase Proteins. New England Journal of Medicine. 2023;388(5):439–52. https://doi.org/10.1056/NEJMra2206346</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Ларина ОН, Беккер АМ. Влияние условий сухой иммерсии на содержание в крови человека глобулиновых белков острой фазы. Вестник восстановительной медицины. 2008;6:29–31. EDN: MUOEGN</mixed-citation><mixed-citation xml:lang="en">Larina ON, Bekker AM. The effect of dry immersion conditions on the content of acute phase globulin proteins in human blood. Bulletin of rehabilitation medicine. 2008;6:29–31 (In Russ.). EDN: MUOEGN</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Ларина ОН, Беккер АМ, Тюрмин-Кузьмин АЮ. Ответ острой фазы в экспериментах с моделированием воздействия невесомости. Интегративная физиология. 2023;4(2):187. https://doi.org/10.33910/2687-1270-2023-4-2-187-197</mixed-citation><mixed-citation xml:lang="en">Larina ON, Bekker AM, Tjurmin-Kuzmin AU. The acute phase response in experiments with modeling the effects of weightlessness. Integrative physiology. 2023;4(2):187 (In Russ.). https://doi.org/10.33910/2687-1270-2023-4-2-187-197</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang Y, Wei X, Browning S, Scuderi G, Hanna L, Wei L. Targeted designed variants of alpha-2-macroglobulin (A2M) attenuate cartilage degeneration in a rat model of osteoarthritis induced by anterior cruciate ligament transection. Arthritis Research and Therapy. 2017;19:1–11. https://doi.org/10.1186/s13075-017-1363-4</mixed-citation><mixed-citation xml:lang="en">Zhang Y, Wei X, Browning S, Scuderi G, Hanna L, Wei L. Targeted designed variants of alpha-2-macroglobulin (A2M) attenuate cartilage degeneration in a rat model of osteoarthritis induced by anterior cruciate ligament transection. Arthritis Research and Therapy. 2017;19:1–11. https://doi.org/10.1186/s13075-017-1363-4</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Sathe S, Sakata M, Beaton A, Sack R. Identification, origins and the diurnal role of the principal serine protease inhibitors in human tear fluid. Current eye research. 1998;17(4):348–62. https://doi.org/10.1080/02713689808951215</mixed-citation><mixed-citation xml:lang="en">Sathe S, Sakata M, Beaton A, Sack R. Identification, origins and the diurnal role of the principal serine protease inhibitors in human tear fluid. Current eye research. 1998;17(4):348–62. https://doi.org/10.1080/02713689808951215</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Bogdanov V, Kim A, Nodel M, Pavlenko T, Pavlova E, Blokhin V, et al. A Pilot Study of Changes in the Level of Catecholamines and the Activity of α-2-Macroglobulin in the Tear Fluid of Patients with Parkinsons Disease and Parkinsonian Mice. International Journal of Molecular Sciences. 2021;22(9):4736. https://doi.org/10.3390/ijms22094736</mixed-citation><mixed-citation xml:lang="en">Bogdanov V, Kim A, Nodel M, Pavlenko T, Pavlova E, Blokhin V, et al. A Pilot Study of Changes in the Level of Catecholamines and the Activity of α-2-Macroglobulin in the Tear Fluid of Patients with Parkinsons Disease and Parkinsonian Mice. International Journal of Molecular Sciences. 2021;22(9):4736. https://doi.org/10.3390/ijms22094736</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Иванов АП, Гончаров ИБ, Репенкова ЛГ. Изменения реологических показателей крови и гемодинамики в условиях 14-суточной антиортостатической гипокинезии. Космическая биология и авиакосмическая медицина. 1990;24(4):30.</mixed-citation><mixed-citation xml:lang="en">Ivanov AP, Goncharov IB, Repenkova LG. Changes in rheological parameters of blood and hemodynamics under conditions of 14-day antiorthostatic hypokinesia. Space biology and aerospace medicine. 1990;24(4):30 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Атьков ОЮ, Бедненко АС. Гипокинезия, невесомость: клинические и физиологические аспекты. М.: Наука, 1989. 304 c.</mixed-citation><mixed-citation xml:lang="en">Atkov OU, Bednenko AS. Hypokinesia, weightlessness: clinical and physiological aspects. Moscow: Nauka Publ., 1989. 304 p. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Marshall-Goebel K, Laurie S, Alferova I, Arbeille P, Aunon-Chancellor S, Ebert D, et al. Assessment of Jugular Venous Blood Flow Stasis and Thrombosis During Spaceflight. JAMA Network Open. 2019;2:e1915011. https://doi.org/10.1001/jamanetworkopen.2019.15011</mixed-citation><mixed-citation xml:lang="en">Marshall-Goebel K, Laurie S, Alferova I, Arbeille P, Aunon-Chancellor S, Ebert D, et al. Assessment of Jugular Venous Blood Flow Stasis and Thrombosis During Spaceflight. JAMA Network Open. 2019;2:e1915011. https://doi.org/10.1001/jamanetworkopen.2019.15011</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Tayal D, Jain P, Goswami B. D-dimer – a multifaceted molecule. Hormone Molecular Biology and Clinical Investigation. 2024;45(2):75–84. https://doi.org/10.1515/hmbci-2022-0093</mixed-citation><mixed-citation xml:lang="en">Tayal D, Jain P, Goswami B. D-dimer – a multifaceted molecule. Hormone Molecular Biology and Clinical Investigation. 2024;45(2):75–84. https://doi.org/10.1515/hmbci-2022-0093</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Найдич ВИ. Основные результаты научных исследований в области радиобиологии за 2018 год. Радиационная биология. Радиоэкология. 2019;59(4):431–46. https://doi.org/10.1134/S086980311904009X</mixed-citation><mixed-citation xml:lang="en">Najdich VI. The main results of scientific research in the field of radiobiology in 2018. Radiation biology. Radioecology. 2019;59(4):431–46 (In Russ.). https://doi.org/10.1134/S086980311904009X</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Кузичкин ДС, Маркин АА, Журавлева ОА, Кривицина ЗА, Вострикова ЛВ, Заболотская ИВ и др. Влияние суммарной продолжительности и количества совершенных космических полетов на систему плазменного гемостаза человека. Физиология человека. 2019;45(6):133–6.</mixed-citation><mixed-citation xml:lang="en">Kuzichkin DS, Markin AA, Zhuravleva OA, Krivicina ZA, Vostrikova LV, Zabolotskaja IV, et al. The effect of the total duration and number of completed space flights on the human plasma hemostasis system. Human physiology. 2019;45(6):133–6 (In Russ.). https://doi.org/10.1134/S0131164619050072</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Муха АЛ, Маркова ОА. О клиническом значении определения некоторых гемостатических показателей в слезной жидкости больных с сосудистыми заболеваниями сетчатки. Вестник офтальмологии. 1994;1:19–20.</mixed-citation><mixed-citation xml:lang="en">Muha AL, Markova OA. On the clinical significance of determining some hemostatic parameters in the lacrimal fluid of patients with retinal vascular diseases. Bulletin of Ophthalmology. 1994;1:19–20 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Мошетова ЛК, Косырев АБ, Цихончук ТВ, Яровая ГА, Туркина КИ, Нешкова ЕА. Оценка региональной фибринолитической активности слезной жидкости путем определения уровня D-димера у пациентов с окклюзией ретинальных вен. Офтальмологические ведомости. 2016;9(4):18–29. https://doi.org/10.17816/OV9418-29</mixed-citation><mixed-citation xml:lang="en">Moshetova LK, Kosyrev AB, Cihonchuk TV, Jarovaja GA, Turkina KI, Neshkova EA. Assessment of regional fibrinolytic activity of lacrimal fluid by determining the level of D-dimer in patients with retinal vein occlusion. Ophthalmological reports. 2016;9(4):18–29 (In Russ.). https://doi.org/10.17816/OV9418-29</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Ong J, Tarver W, Brunstetter T, Mader T, Gibson C, Mason S, Lee A. Spaceflight associated neuro-ocular syndrome: proposed pathogenesis, terrestrial analogues, and emerging countermeasures. British Journal of Ophthalmology. 2023;107(7):895–900. https://doi.org/10.1136/bjo-2022-322892</mixed-citation><mixed-citation xml:lang="en">Ong J, Tarver W, Brunstetter T, Mader T, Gibson C, Mason S, Lee A. Spaceflight associated neuro-ocular syndrome: proposed pathogenesis, terrestrial analogues, and emerging countermeasures. British Journal of Ophthalmology. 2023;107(7):895–900. https://doi.org/10.1136/bjo-2022-322892</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Willcox M, Argueso P, Georgiev G, Holopainen J, Laurie G, Millar T, et al. TFOS DEWS II Tear Film Report. The ocular surface. 2017;15(3):366–403. https://doi.org/10.1016/j.jtos.2017.03.006</mixed-citation><mixed-citation xml:lang="en">Willcox M, Argueso P, Georgiev G, Holopainen J, Laurie G, Millar T, et al. TFOS DEWS II Tear Film Report. The ocular surface. 2017;15(3):366–403. https://doi.org/10.1016/j.jtos.2017.03.006</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Botelho S, Goldstein A, Rosenlund M. Tear sodium, potassium, chloride, and calcium at various flow rates: children with cystic fibrosis and unaffected siblings with and without corneal staining. The Journal of Pediatrics. 1973;83(4):601–6. https://doi.org/10.1016/s0022-3476(73)80221-5</mixed-citation><mixed-citation xml:lang="en">Botelho S, Goldstein A, Rosenlund M. Tear sodium, potassium, chloride, and calcium at various flow rates: children with cystic fibrosis and unaffected siblings with and without corneal staining. The Journal of Pediatrics. 1973;83(4):601–6. https://doi.org/10.1016/s0022-3476(73)80221-5</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Stern M, Gao J, Siemasko K, Beuerman R, Pflugfelder S. The role of the lacrimal functional unit in the pathophysiology of dry eye. Experimental eye research. 2004;78(3):409–6. https://doi.org/10.1016/j.exer.2003.09.003</mixed-citation><mixed-citation xml:lang="en">Stern M, Gao J, Siemasko K, Beuerman R, Pflugfelder S. The role of the lacrimal functional unit in the pathophysiology of dry eye. Experimental eye research. 2004;78(3):409–6. https://doi.org/10.1016/j.exer.2003.09.003</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Eyal S. How do the pharmacokinetics of drugs change in astronauts in space. Expert opinion on drug metabolism &amp; toxicology. 2020;16(5):353–6. https://doi.org/10.1080/17425255.2020.1746763</mixed-citation><mixed-citation xml:lang="en">Eyal S. How do the pharmacokinetics of drugs change in astronauts in space. Expert opinion on drug metabolism &amp; toxicology. 2020;16(5):353–6. https://doi.org/10.1080/17425255.2020.1746763</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Seoane-Viano I, Ong J, Basit A, Goyanes A. To infinity and beyond: Strategies for fabricating medicines in outer space. International Journal of Pharmaceutics. 2022;4:100121. https://doi.org/10.1016/j.ijpx.2022.100121</mixed-citation><mixed-citation xml:lang="en">Seoane-Viano I, Ong J, Basit A, Goyanes A. To infinity and beyond: Strategies for fabricating medicines in outer space. International Journal of Pharmaceutics. 2022;4:100121. https://doi.org/10.1016/j.ijpx.2022.100121</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Ponzini E. Tear biomarkers. Advances in Clinical Chemistry. 2024;120:69–115. https://doi.org/10.1016/bs.acc.2024.03.002</mixed-citation><mixed-citation xml:lang="en">Ponzini E. Tear biomarkers. Advances in Clinical Chemistry. 2024;120:69–115. https://doi.org/10.1016/bs.acc.2024.03.002</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Loescher M, Seiz C, Hurst J, Schnichels S. Topical drug delivery to the posterior segment of the eye. Pharmaceutics. 2022;14(1):134. https://doi.org/10.3390/pharmaceutics14010134</mixed-citation><mixed-citation xml:lang="en">Loescher M, Seiz C, Hurst J, Schnichels S. Topical drug delivery to the posterior segment of the eye. Pharmaceutics. 2022;14(1):134. https://doi.org/10.3390/pharmaceutics14010134</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
